Görg S - Search Results

1

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2.

Markewitz RDH, Juhl D, Pauli D, Görg S, Junker R, Rupp J, Engel S, Steinhagen K, Herbst V, Zapf D, Krüger C, Brockmann C, Leypoldt F, Dargvainiene J, Schomburg B, Sharifzadeh SR, Salek Nejad L, Wandinger KP, Ziemann M. Markewitz RDH, et al. Among authors: gorg s. Vaccines (Basel). 2022 Apr 20;10(5):649. doi: 10.3390/vaccines10050649. Vaccines (Basel). 2022. PMID: 35632405 Free PMC article.

2

The natural course of primary cytomegalovirus infection in blood donors.

Ziemann M, Unmack A, Steppat D, Juhl D, Görg S, Hennig H. Ziemann M, et al. Among authors: gorg s. Vox Sang. 2010 Jul 1;99(1):24-33. doi: 10.1111/j.1423-0410.2009.01306.x. Epub 2010 Jan 13. Vox Sang. 2010. PMID: 20074081

3

Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.

Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Juhl D, et al. Among authors: gorg s. Transfusion. 2011 Jul;51(7):1477-85. doi: 10.1111/j.1537-2995.2010.03031.x. Epub 2011 Jan 28. Transfusion. 2011. PMID: 21276000

4

Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.

Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S. Ziemann M, et al. Among authors: gorg s. Clin Transplant. 2012 Jul-Aug;26(4):644-56. doi: 10.1111/j.1399-0012.2012.01615.x. Epub 2012 Mar 20. Clin Transplant. 2012. PMID: 22432638

5

Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.

Ziemann M, Heuft HG, Frank K, Kraas S, Görg S, Hennig H. Ziemann M, et al. Among authors: gorg s. Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320406

6

Seroprevalence and incidence of hepatitis E virus infection in German blood donors.

Juhl D, Baylis SA, Blümel J, Görg S, Hennig H. Juhl D, et al. Among authors: gorg s. Transfusion. 2014 Jan;54(1):49-56. doi: 10.1111/trf.12121. Epub 2013 Feb 26. Transfusion. 2014. PMID: 23441647

7

Comparison of the two fully automated anti-HCMV IgG assays: Abbott Architect CMV IgG assay and Biotest anti-HCMV recombinant IgG ELISA.

Juhl D, Vockel A, Luhm J, Ziemann M, Hennig H, Görg S. Juhl D, et al. Among authors: gorg s. Transfus Med. 2013 Jun;23(3):187-94. doi: 10.1111/tme.12036. Epub 2013 Apr 11. Transfus Med. 2013. PMID: 23578169

8

The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.

Ziemann M, Juhl D, Görg S, Hennig H. Ziemann M, et al. Among authors: gorg s. Transfusion. 2013 Oct;53(10):2183-9. doi: 10.1111/trf.12199. Epub 2013 Apr 15. Transfusion. 2013. PMID: 23581526

9

Parvovirus b19 infections and blood counts in blood donors.

Juhl D, Steppat D, Görg S, Hennig H. Juhl D, et al. Among authors: gorg s. Transfus Med Hemother. 2014 Feb;41(1):52-9. doi: 10.1159/000357650. Epub 2013 Dec 30. Transfus Med Hemother. 2014. PMID: 24659948 Free PMC article.

10

Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.

Juhl D, Görg S, Hennig H. Juhl D, et al. Among authors: gorg s. Vox Sang. 2014 Oct;107(3):226-32. doi: 10.1111/vox.12162. Epub 2014 Jun 11. Vox Sang. 2014. PMID: 24916600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters